Search the Newsreel

Omnicell (OMCL) Could Be 30% Undervalued If Its OmniSphere Shift Pays Off

Omnicell (OMCL) is attracting attention due to recent share price movements and its strategic shift towards the cloud-native OmniSphere platform, which aims to simplify medication management and boost recurring SaaS-based revenues. While a popular narrative suggests the company is 29.8% undervalued with a fair …

Omnicell Inc (OMCL) Earnings Forecast: Future EPS & Revenue Growth Estimates

Omnicell Inc (OMCL) currently has an earnings forecast score of 8.00, placing it 68th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $47.00, with a majority recommending a "Buy" trend for the stock. The company's expected revenue …

Omnicell Inc (OMCL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Omnicell Inc (OMCL), noting its current valuation score of 6.66, ranking 178 out of 200 in the Healthcare Equipment & Supplies industry. The company's P/E ratio stands at 91.94, which is significantly below its recent high but …

Omnicell, Inc. Revenue Breakdown – NASDAQ:OMCL

Omnicell Inc (OMCL) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Omnicell Inc (OMCL) stock, including its current trading price, market capitalization, and P/E ratio. It specifically addresses the company's dividend history, noting that no dividends have been distributed over the past five years. The page indicates there is …

OMCL|Omnicell Inc|Price:39.845|Chg%:-1.015

Omnicell Inc. (OMCL) is a provider of medication management solutions and adherence tools for health systems and pharmacies, focusing on transforming pharmacy care through innovation. The company's solutions utilize robotics, smart devices, intelligent software, and services to optimize clinical and business outcomes. Omnicell's offerings …

Price to book forward of Omnicell, Inc. – BX:OC9

This article provides the "Price to book forward" financial metric for Omnicell, Inc. (BX:OC9). It appears to be a stub or data-focused page from TradingView, indicating the value and changes for this specific financial ratio over a period. The page also lists various related …

Omnicell (OMCL) Stock Forum and Discussion

This article provides a forum for discussion regarding Omnicell (OMCL) stock. It includes a basic stock quote for OMCL, showing its last price, change, and percentage change. The article encourages users to share their opinions and insights on Omnicell's future performance.

Omnicell to Report Q2 Earnings: OmniSphere in Focus

Omnicell (OMCL) is scheduled to release its second-quarter 2026 earnings on July 30, with expectations for revenue growth to reach $309.6 million and earnings per share of 48 cents. The company's performance is anticipated to be driven by its Connected Devices strategy, expanding recurring …

(OMCL) Risk Channels and Responsive Allocation

This article provides an analysis of Omnicell Inc. (OMCL), highlighting strong sentiment across all time horizons supporting an overweight bias. It details an exceptional 57.2:1 risk-reward setup targeting a 16.8% gain versus a 0.3% risk. The analysis also outlines three distinct AI-generated institutional trading …

Omnicell (OMCL) chief reports 10,000-share sale at $47 via trust

Omnicell, Inc. CEO Randall A. Lipps reported an indirect sale of 10,000 shares of common stock at $47.00 per share on July 15, 2026, executed through a Rule 10b5-1 trading plan adopted in February 2026. The shares were held in a trust with his …

[144] OMNICELL, INC. SEC Filing

This article details an SEC Form 144 filing by Omnicell, Inc. concerning the proposed sale of 10,000 shares of common stock with an aggregate market value of $470,000. The shares were acquired by "Common Merrill Lynch" on January 16, 2021, through equity compensation. The …